Go Pro

Aemetis (NASDAQ:AMTX) Rating Increased to Hold at Wall Street Zen

Aemetis logo with Energy background
Image from MarketBeat Media, LLC.

Key Points

  • Wall Street Zen upgraded Aemetis from “sell” to “hold,” while analyst opinions remain mixed. The stock has an average “Hold” rating and a consensus price target of $11.88, including a $22 buy target from Ascendiant Capital Markets and a “sell” rating from Weiss Ratings.
  • Aemetis shares opened at $2.07, with a market capitalization of approximately $149.4 million and a 52-week range of $1.30 to $3.80. The company reported a quarterly loss of $0.13 per share, better than the expected $0.29 loss, but revenue of $62.7 million fell short of estimates.
  • Institutional investors and hedge funds own 27.02% of Aemetis, with Bank of America and Royal Bank of Canada among investors that recently increased their positions. The company produces renewable fuels and renewable natural gas through its advanced fuels and Aemetis RNG segments.
  • Interested in Aemetis? Here are five stocks we like better.

Aemetis (NASDAQ:AMTX - Get Free Report) was upgraded by investment analysts at Wall Street Zen from a "sell" rating to a "hold" rating in a research note issued to investors on Saturday.

Several other research analysts have also issued reports on AMTX. Ascendiant Capital Markets raised their price target on Aemetis from $21.00 to $22.00 and gave the stock a "buy" rating in a research report on Friday, May 22nd. Weiss Ratings reiterated a "sell (e+)" rating on shares of Aemetis in a report on Friday, July 17th. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $11.88.

View Our Latest Research Report on Aemetis

Aemetis Price Performance

Aemetis stock opened at $2.07 on Friday. The stock has a fifty day moving average price of $1.70 and a two-hundred day moving average price of $2.07. Aemetis has a 52-week low of $1.30 and a 52-week high of $3.80. The firm has a market capitalization of $149.39 million, a P/E ratio of -2.27 and a beta of 1.48.

Aemetis (NASDAQ:AMTX - Get Free Report) last issued its earnings results on Thursday, August 6th. The specialty chemicals company reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.29) by $0.16. The firm had revenue of $62.70 million during the quarter, compared to analyst estimates of $67.69 million. On average, equities research analysts predict that Aemetis will post -0.98 EPS for the current fiscal year.

Hedge Funds Weigh In On Aemetis

Large investors have recently bought and sold shares of the company. Bank of America Corp DE increased its stake in Aemetis by 148.3% in the 1st quarter. Bank of America Corp DE now owns 101,486 shares of the specialty chemicals company's stock valued at $324,000 after buying an additional 60,611 shares during the last quarter. Royal Bank of Canada boosted its stake in shares of Aemetis by 10,632.5% during the 1st quarter. Royal Bank of Canada now owns 8,908 shares of the specialty chemicals company's stock worth $28,000 after buying an additional 8,825 shares during the last quarter. Virtu Financial LLC acquired a new position in shares of Aemetis during the 4th quarter worth about $31,000. HRT Financial LP bought a new position in shares of Aemetis in the 4th quarter valued at about $36,000. Finally, Centiva Capital LP acquired a new stake in shares of Aemetis in the third quarter valued at about $39,000. Institutional investors and hedge funds own 27.02% of the company's stock.

About Aemetis

(Get Free Report)

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Aemetis Right Now?

Before you consider Aemetis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aemetis wasn't on the list.

While Aemetis currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines